<DOC>
	<DOCNO>NCT01386164</DOCNO>
	<brief_summary>The purpose study analyze compare immunogenicity Bivalent Tetravalent vaccine Human Papillomavirus HIV-infected adult person .</brief_summary>
	<brief_title>Immune Response Bivalent Tetravalent Human Papillomavirus Vaccine HIV Infected Adults</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>HIV positive subject . Age 18 time first vaccination . Written inform consent obtain subject . Subjects investigator believe comply requirement protocol . If currently antiretroviral therapy ( ART ) , subject must compliant triple therapy ( highly active ART ) undetectable viral load period six month prior study entry . Female subject nonchildbearing potential may enrol study . Female subject childbearing potential may enrol study , subject negative pregnancy test screen day vaccination , agree continue adequate contraception entire treatment period . Previous vaccination HPV , plan administration HPV vaccine foreseen study protocol study period ( Day 0 Month 12 ) . Pregnant breastfeed female . Previous enrollment study . Subjects investigator believe and/or comply requirement protocol ( i.e . abuse drug alcohol , dementia give medical , psychiatric , social work related condition ) . Chronic administration immunosuppressive drug Cancer autoimmune disease Previous allergic reaction vaccination Known allergy towards component either test drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>